SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0000950123-09-000083
Filing Date
2009-01-05
Accepted
2009-01-05 17:18:57
Documents
1
Period of Report
2008-12-29
Filing Date Changed
2009-01-05
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y73690e8vk.htm 8-K 35298
  Complete submission text file 0000950123-09-000083.txt   36951
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15875 | Film No.: 09506608
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1